Cryoport provides temperature-controlled supply chain solutions for the life sciences, with a strong focus on cryogenic logistics for cell and gene therapies, biopharma, animal health, and reproductive medicine. It offers specialized shippers, condition monitoring, biostorage, and cryopreservation services that protect high-value biological materials in transit and storage. The company also manufactures cryogenic freezers, dewars, and related equipment used by laboratories and therapy developers worldwide.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 41 | — | -14 | — |
| Q2 2025 | 45.5 | — | 106.9 | — |
| Q3 2025 | 44.2 | — | -8.9 | — |
| Q4 2025 | 45.5 | — | -13.6 | — |
| Q1 2026 | 47.8 | 16.5% | -12.5 | — |
| Q2 2026 | 49 | 7.7% | -10.3 | -109.6% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Southern Missouri Bancorp, Inc. (SMBC), Transcat, Inc. (TRNS), Hertz Global Holdings, Inc. (HTZ), MidCap Financial Investment Corporation (MFIC), Horizon Quantum Holdings Ltd. (HQ), CoinShares PLC (CSHR)